DAVID QUAN SHIH, MD
Osteopathic Medicine at Alameda St, Los Angeles, CA
License number
California A87912
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address
2
100 S Alameda St UNIT 135, Los Angeles, CA 90012
8530 W Sunset Rd STE 230, Las Vegas, NV 89113
8530 W Sunset Rd STE 230, Las Vegas, NV 89113
Phone
(626) 660-5846
(310) 423-0224 (Fax)
(310) 423-0224 (Fax)
Personal information
See more information about DAVID QUAN SHIH at radaris.comName
Address
Phone
39663 Leslie St APT 387, Fremont, CA 94538
46 W Julian St UNIT 334, San Jose, CA 95110
508 S 11Th St APT 10, San Jose, CA 95112
5326 Foxhound Way, San Diego, CA 92130
55 Bassett St, San Jose, CA 95110
Professional information
See more information about DAVID QUAN SHIH at trustoria.com
Dr. David Q Shih - MD (Doctor of Medicine)
Dr. David Q Shih - MD (Doctor of Medicine)
Hospitals:
Inflammatory Bowel Disease Ctr
8730 Alden Dr SUITE 2E, Los Angeles 90048
Inflammatory Bowel Disease Ctr
8730 Alden Dr SUITE 2E, Los Angeles 90048
8730 Alden Dr SUITE 2E, Los Angeles 90048
Inflammatory Bowel Disease Ctr
8730 Alden Dr SUITE 2E, Los Angeles 90048
Education:
Medical Schools
Weill Cornell Medical College
Graduated: 1998
Weill Cornell Medical College
Graduated: 1998
Md At Cedars-Sinai Medical Center
Md At Cedars-Sinai Medical Center
Position:
MD at Cedars-Sinai Medical Center
Location:
Greater Los Angeles Area
Industry:
Hospital & Health Care
Work:
Cedars-Sinai Medical Center
-
MD
Tl1A Model Of Inflammation Fibrosis And Autoimmunity
Tl1A Model Of Inflammation Fibrosis And Autoimmunity
US Patent:
2012007, Mar 29, 2012
Filed:
Sep 22, 2011
Appl. No.:
13/240117
Inventors:
David Q. Shih - Los Angeles CA, US
Stephen R. Targan - Santa Monica CA, US
Stephen R. Targan - Santa Monica CA, US
Assignee:
CEDARS-SINAI MEDICAL CENTER - Los Angeles CA
International Classification:
A01K 67/027, C12N 5/10, G01N 33/48, C12N 15/85
US Classification:
800 3, 800 9, 800 21, 435352
Abstract:
This invention relates transgenic animals that overexpress TL1A in a tissue specific manner to model inflammatory bowel disease (IBM such as colitis, Crohn's disease and ulcerative colitis, fibrosis, and related inflammatory diseases and conditions. TL1A transgenic animals constitutively express both TL1A and GFP in lymphoid and myeloid cell lineages, allowing convenient identification and sorting of immune cells involved in IBD disease progression, such as T-cells, antigen presenting cells (APC), and dendritic cells (DC). TL1A transgenic animals may be induced to exhibit gross fibrosis, or isolated cells may be implanted into immunodeficient mice to establish colitis.
Program Ops Director At Raytheon Space And Airborne Systems
Program Ops Director At Raytheon Space And Airborne Systems
Position:
Program OPs Director at Raytheon Space and Airborne Systems
Location:
Greater Los Angeles Area
Industry:
Defense & Space
Work:
Raytheon Space and Airborne Systems
-
Program OPs Director
Analyst At Indymac Bank
Analyst At Indymac Bank
Position:
Analyst at Indymac Bank
Location:
Greater Los Angeles Area
Industry:
Banking
Work:
Indymac Bank
-
Analyst
Education:
University of Southern California - Marshall School of Business 2000 - 2004
David Quan Shih, West Hollywood CA
David Quan Shih, West Hollywood CA
Specialties:
Internal Medicine, Gastroenterology
Work:
Cedars-Sinai Medical Center
8700 Beverly Blvd, Los Angeles, CA 90048
8700 Beverly Blvd, Los Angeles, CA 90048
Education:
Cornell University (2003) *, Stanford Hospital and Clinics (2005) *Internal Medicine, UCLA Medical Center (2009) *Gastroenterology
Operations At Benmex International Inc.
Operations At Benmex International Inc.
Position:
Operations at Benmex International Inc.
Location:
Greater Los Angeles Area
Industry:
Wholesale
Work:
Benmex International Inc.
-
Operations